Quantitative analysis of von Willebrand factor propeptide release in vivo: Effect of experimental endotoxemia and administration of 1-deamino-8- D-arginine vasopressin in humans

Blood

Volumn 88, Issue 8, 1996, Pages 2951-2958

  Borchiellini, Alessandra ^b   Fijnvandraat, Karin ^b   Ten Cate, Jan Wouter ^b   Pajkrt, Dasja ^b   Van Deventer, Sander J H ^b   Pasterkamp, Gerard ^b   Meijer Huizinga, Fenny ^b   Zwart Huinink, Lineke ^b   Voorberg, Jan ^b   Van Mourik, Jan A ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; ENDOTOXIN; PROTEIN PRECURSOR; VON WILLEBRAND FACTOR;

ANIMAL CELL; ARTICLE; ENDOTHELIUM CELL; ENDOTOXEMIA; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; QUANTITATIVE ASSAY; STOICHIOMETRY;

EID: 10244266470     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.8.2951.bloodjournal8882951     Document Type: Article

References (37)

1. Wagner DD: Cell biology of von Willebrand factor. Annu Rev Cell Biol 6:217, 1990
2. Sadler JE: von Willebrand factor. J Biol Chem 266:22777, 1991
3. Fay PJ, Kawai Y, Wagner DD, Ginsburg D, Bonthron D, Ohlsson-Wilhelm BM, Chavin SI, Abraham GN, Handin RI, Orkin SH, Montgomery RR. Marder VJ: Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science 232:995, 1986
4. Carew JA, Browning PJ, Lynch DC: Sulfation of von Willebrand factor. Blood 76:2530, 1990
5. Levine JD, Harlan JM, Harker LA, Joseph ML, Counts RB: Thrombin-mediated release of factor VIII-related antigen from human umbilical vein endothelial cells in culture. Blood 60:531, 1982
6. Loesberg C, Gonsalves MD, Zandbergen J, Willems Ch, van Aken WG, Stel HV, van Mourik JA, de Groot PG: The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. Biochim Biophys Acta 763:160, 1983
7. Wagner DD, Marder VJ: Biosynthesis of von Willebrand protein by human endothelial cells: Processing steps and their intracellular localization. J Cell Biol 99:2123, 1984
8. Reinders JH, de Groot PG, Gonsalves MD, Zandbergen J, Loesberg C, van Mourik JA: Isolation of a storage and secretory organelle containing von Willebrand protein from cultured human endothelial cells. Biochim Biophys Acta 804:361, 1984
9. Sporn LA, Marder VJ. Wagner DD: Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 46:185, 1986
10. Federici AB, Pagani BS, Colibretti ML, DeMarco L, Manucci PM: Binding of von Willebrand factor to glycoproteins Ib and IIIb/IIIa complex: Affinity is related to multimeric size. Br J Haematol 73:93, 1989
11. Wagner DD, Fay PJ, Sporn LA, Sinha S, Lawrence SO, Marder VJ: Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells. Proc Natl Acad Sci USA 84:1955, 1987
12. Van de Ven WJM, Voorberg J, Fontijn R, Pannekoek H, Van den Ouweland AMW, Van Duijnhoven HLP, Roebroek AJM, Siezen RJ: Furin is a subtlisin-like proprotein processing enzyme in higher eukaryotes. Mol Biol Rep 14:265, 1990
13. Leyte A, Voorberg J, van Schijndel HB, Duim B, Pannekoek H, van Mourik JA: The propolypeptide of von Willebrand factor is required for the formation of a functional factor VIII binding site in mature von Willebrand factor. Biochem J 274:257, 1991
14. Jaffe EA, Nachman NL, Becker CG, Minick CR: Culture of human cell derived from umbilical veins. Identification by morphologic criteria. J Clin Invest 52:2745, 1973
15. Willems C, Astaldi GCB, de Groot P, Janssen MC, Gonsalves MB, Zeijlemaker WP, van Mourik JA: Media conditioned by cultured human vascular endothelial cells inhibit the growth of vascular smooth muscle cells. Exp Cell Res 139:191, 1982
16. Voorberg J, Fontijn R, van Mourik JA, Pannekoek H: Domains involved in multimer assembly of von Willebrand factor (vWf): Multimerization is independent of dimerization. EMBO J 9:797, 1990
17. Sixma JJ, Sakariassen KS, Stel HV, Houdijk WPM, In der Maur DW, Hamer RJ, de Groot PG, van Mourik JA: Functional domains on von Willebrand factor. J Clin Invest 74:736, 1984
18. Hakkert BC, Rentenaar JM, van Mourik JA: Monocytes enhance endothelial von Willebrand factor release and prostacyclin production with different kinetics and dependency on intercellular contact between these two cell types. Br J Haematol 80:495, 1992
19. Stel HV, Sakariassen KS, Scholte BJ, Veerman ECI, van der Kwast TH, de Groot PG, Sixma JJ, van Mourik JA: Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: Relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium. Blood 63:1408, 1984
20. Fay PJ: Factor VIII structure and function. Thromb Haemost 70:63, 1993
21. Levi M, ten Cate JW, Dooiewaard G, Sturk A, Brommer EJP, Agnelli G: DDAVP induces systemic release of urokinase-type plasminogen activator. Thromb Haemost 62:686, 1989
22. Leyte A, Mertens K, Distel B, Evers RF, de Keyzer-Nellen MJM, Groenen-van Dooren MMCL, de Bruin J, Pannekoek H, van Mourik JA, Verbeet MP: Inhibition of human coagulation factor VIII by monoclonal antibodies; mapping of functional epitopes with the use of recombinant factor VIII fragments. Biochem J 263:187, 1989
23. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248, 1989
24. Nakane PK, Kawaoi A: Peroxidase-labeled antibody: A new method of conjugation. J Histochem Cytochem 22:1084, 1974
25. Takagi J, Fujisawa T, Sekiya F, Saito Y: Collagen-binding domain within bovine propolypeptide of von Willebrand factor. J Biol Chem 266:5575, 1991
26. Usui T, Takagi J, Saito Y: Propolypeptide of von Willebrand factor serves as a substrate for factor XIIIa and is cross-linked to laminin. J Biol Chem 268:12311, 1993
27. Takagi J, Aoyama T, Ueki S, Ohba H, Saito Y, Lorand L: Identification of factor XIIIa-reactive glutamyl residues in the propolypeptide of bovine von Willebrand factor. Eur J Biochem 232:773, 1995
28. Kao J, Fan Y, Yan SD, Kisiel W, Tijburg P, van Mourik JA, Stern D: von Willebrand antigen II (VWFAgII) links activation of coagulation and the inflammatory response. Thromb Haemost 69:265, 1993 (abstr)
29. Clauss M, Knies U, Risau W, Pötschz B: Vascular permeability/vascular endothelial growth factor (VPF/VEGF) and histamin induction of tissue factor (TF) on endothelial cells is linked to the release and action of von Willebrand factor propolypeptide (provWF). VIIIth International Symposium on the Biology of Vascular Cells. Heidelberg, Germany, August 30-September 4, 1994 (abstr)
30. Ewenstein BM, Warhol MJ, Handin RI, Pober JS: Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells. J Cell Biol 104:1423, 1987
31. McCarroll DR, Ruggeri ZM, Montgomery RR: The effect of DDAVP on plasma levels of von Willebrand antigen II in normal individuals and patients with von Willebrand's disease. Blood 63:532, 1984
32. McCarroll DR, Ruggeri ZM, Montgomery RR: Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: Discrimination between type I and type II von Willebrand's disease. J Lab Clin Med 103:704, 1984
33. Kanwar S, Woodman RC, Poon MC, Murohara T, Lefer AM, Davenpeck KL, Kubus P: Desmopressin induces endothelial P-Selectin expression and leukocyte rolling in postcapillary venules. Blood 86:2760, 1995
34. Tsakiris DA, Haefeli WE, Linder L, Steiner B, Marbet GA: Platelet surface activation markers after DDAVP infusion in healthy subjects. Thromb Haemost 74:990, 1995
35. Vischer VM, Wagner DD: von Willebrand Factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. Blood 83:3536, 1994
36. Dillen L, Miserez B, Claeys M, Aunis D, De Potter W: Post-translational processing of proenkephalins and chromogranins/secretogranins. Neurochem Int 22:315, 1993
37. Hook VYH, Azaryan AV, Hwang SR, Tezapsidis N: Proteases and the emerging role of protease inhibitors in prohormone processing. FASEB J 8:1269, 1994